Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.96% | $1.19B | €455.71B | 66.74% | 76 Outperform | |
| Roche Holding AG | 1.13% | $688.78M | CHF280.54B | 43.37% | 73 Outperform | |
| HSBC Holdings | 1.08% | $654.88M | £224.31B | 48.12% | 80 Outperform | |
| Novartis AG | 1.06% | $648.63M | CHF230.29B | 23.72% | 80 Outperform | |
| AstraZeneca | 1.02% | $620.41M | £219.61B | 20.01% | 80 Outperform | |
| Nestlé SA | 0.91% | $557.03M | CHF199.61B | 19.19% | 71 Outperform | |
| Toyota Motor | 0.90% | $547.06M | ¥48.41T | 32.64% | 80 Outperform | |
| Royal Bank Of Canada | 0.87% | $532.75M | $245.41B | 47.13% | 75 Outperform | |
| Siemens | 0.79% | $482.15M | €201.39B | 20.73% | 74 Outperform | |
| Shell (UK) | 0.79% | $478.32M | £160.27B | 4.83% | 73 Outperform |